Fig. 3
Treatment network meta-analysis and ranking. Other vs. control, “other” refers to antibiotics, “control” contains placebo, no antibiotics, ascorbic acid, and no treatment; Tau2/tau, quantifying heterogeneity; I2, quantifying inconsistency; MD, mean deviation; OR, odds ratio. A Comparisons of defervescence time for antibiotics and control. The subgroups are cases in children, patients without jaundice or severe disease, and patients with jaundice or severe disease. Cases in children include case studies of children. B Comparisons of mortality for antibiotics and controls. C Comparisons of hospital stays for antibiotics and controls